OncoNano Medicine
Alexander Eggermont is currently the Scientific Advisor at OncoNano Medicine. Alexander has also previously served as a member of the Board of Directors for ASCO and EORTC. Dr. Eggermont has also been involved with the European School of Oncology, where they served as a member of the Advisory Board and helped develop the Translational Research Program. In addition, they have also been involved with the EASO (Europe-Arab School of Oncology) program, the Eurasian Program, and the Europe-America Dialogue.
Alexander Eggermont is a medical doctor and surgeon who also has a PhD in tumor biology. Alexander was educated at Erasmus University Rotterdam.
This person is not in the org chart
This person is not in any offices
OncoNano Medicine
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents.